| Schedule of Disaggregated Revenue |
The following table presents disaggregated revenue in the following categories (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Contract Types: | | | | | | | | | Licensing | $ | 595 | | | $ | 1,050 | | | $ | 1,190 | | | $ | 2,101 | | | Engineering and other services | 3,271 | | | 1,893 | | | 9,657 | | | 3,695 | | | Biorefining revenue | $ | 3,866 | | | $ | 2,943 | | | $ | 10,847 | | | $ | 5,796 | | | | | | | | | | | Joint development agreements | 275 | | | 1,313 | | | 275 | | | 2,363 | | | Contract research | 1,031 | | | 1,010 | | | 2,020 | | | 2,386 | | | Joint development and contract research revenue | $ | 1,306 | | | $ | 2,323 | | | $ | 2,295 | | | $ | 4,749 | | | | | | | | | | | CarbonSmart product | 3,842 | | | 3,818 | | | 7,892 | | | 8,022 | | | | | | | | | | Total Revenue | $ | 9,014 | | | $ | 9,084 | | | $ | 21,034 | | | $ | 18,567 | |
The following table presents revenue from partners in collaborative arrangements and from grant contributions which are included in the table above as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | Revenue from partners in collaborative agreements included in the Joint development agreements above | $ | 275 | | | $ | 1,313 | | | $ | 275 | | | $ | 2,363 | | Revenue from grant contributions included in Engineering and other services above | — | | | (5) | | | 2,815 | | | 50 | |
The following table presents disaggregation of the Company’s revenues by customer location for the three and six months ended June 30, 2026 and 2025 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | North America | $ | 1,697 | | | $ | 2,649 | | | $ | 4,282 | | | $ | 5,614 | | | Europe, Middle East, Africa (EMEA) | 2,460 | | | 1,954 | | | 7,478 | | | 4,464 | | | Asia | 4,857 | | | 4,481 | | | 9,274 | | | 8,489 | | | | | | | | | | Total Revenue | $ | 9,014 | | | $ | 9,084 | | | $ | 21,034 | | | $ | 18,567 | |
|
| Schedule of Changes in Contract Assets and Liabilities |
The following table provides changes in contract assets and liabilities (in thousands): | | | | | | | | | | | | | | | | | | | Current Contract Assets | | Current Contract Liabilities | | Non-current Contract Liabilities | | Balance as of December 31, 2025 | $ | 6,541 | | | $ | 423 | | | $ | 5,896 | | | Additions to unbilled accounts receivable | 17,728 | | | — | | | — | | | Increases due to consideration received | — | | | 7,731 | | | — | | | Increase due to pre-billing | — | | | 57 | | | — | | | Unbilled accounts receivable recognized in trade receivables | (21,603) | | | — | | | — | | | Allowance on doubtful contract assets | (64) | | | | | | | Increase on revaluation on currency | (77) | | | 1 | | | (171) | | | Reclassification to revenue because of performance obligations satisfied | — | | | (2,359) | | | — | | | | | | | | | Balance as of June 30, 2026 | $ | 2,525 | | | $ | 5,853 | | | $ | 5,725 | |
|